Skip to main content
. 2011 Nov;13(11):811–816. doi: 10.1111/j.1477-2574.2011.00365.x

Table 2.

Agents used when chemotherapy administered

Agent Given per cent (N) Not given per cent (N) Data missing per cent (N)
Chemotherapy in cohort overall 60% (133) 40% (88)

5-FU 70% (93) 0.7% (1) 29.3% (39)

Oxaliplatin + 5FU 33%* (44) 34% (45) 33% (44)

Irinotecan 0% 77.4% (103) 22.6% (30)
*

All those who had oxaliplatin also had 5-FU.